eMedevents
  • 143,476+ Medical Conferences
  • 281 Specialties
  • 10,815 Organizers
  • 154,041 Speakers
  • 156 Countries
  • 4,643 Cities
47,825+
CME Conference Registrations Sold
Home  >  Board Review Courses  >  Third Annual Precision Medicine Symposium: Therapeutic Advances in Hematological and Solid Tumors
CME : 4.75 | Contact Hours : 4.75

Third Annual Precision Medicine Symposium: Therapeutic Advances in Hematological and Solid Tumors

Mar 08, 2020   |   Lexington, Kentucky  United States of America
Organized by : UK HealthCare CECentral
Specialties : Haematology
 
Conference Brochure

Third Annual Precision Medicine Symposium: Therapeutic Advances in Hematological and Solid Tumors is organized by UK HealthCare CECentral and will be held on Mar 08, 2020 at Lexington Griffin Gate Marriott Resort & Spa, Lexington, Kentucky, United States of America.

Accreditation:
CME:

The University of Kentucky College of Medicine designates this live activity for a maximum of 4.75 AMA PRA Category 1 Credit(s)™.

Nursing:
This educational activity is offered for a maximum of 4.75 ANCC contact hours.

Other:
UK Healthcare CECentral certifies this activity for 4.75 hours of participation.

Target Audience:
Oncologists, hematologists, oncology surgeons, pathologists, radiologists, oncology nurses, researchers, clinical research staff, pharmacists, genetic counselors, cancer center administrators and cancer program leaders are encouraged to attend.

Description:
This symposium highlights new advances in liquid biopsies and treatment options for lymphomas. Attendees will also learn strategies for implementing germline testing and CAR T-cell programs and the latest clinical advances in hematological malignancies and GI malignancies, including hyperthermic intraperitoneal chemotherapy (HIPEC).

Objectives:
Upon completion of this activity, participants will be able to:
• List new treatment options for neuroendocrine tumors
• Outline patient specific recommendations for managing neuroendocrine tumors
• Describe the role of hyperthermic intraperitoneal chemotherapy (HIPEC) in the management of GI cancers
• Discuss the role intraarterial chemotherapy to target metastatic liver lesions
• Explain the role of CYP2D6 genotyping in the use of tamoxifen
• Discuss implementation strategies for common drug metabolizing agents and their use in oncology
• Describe the place in therapy of hypomethylating agents, sorafenib, ivosidenib, and enasidenib
• Recognize and manage adverse effects associated with these agents

Registration Desk

Contact No. : 859-218-1034
Email:
marissa.schuh@uky.edu

Conference Fee Details

Conference Fee : NA
Early Fee : NA
Early Fee Last date : NA

  • Drive Walk Transit Bicycle

Venue Address

Lexington Griffin Gate Marriott Resort & Spa
1800 Newtown Pike
Lexington, Kentucky, United States of America

Official Hotel

Lexington Griffin Gate Marriott Resort & Spa,

1800 Newtown Pike,

Lexington, Kentucky, United States of America 40511,

+1 859-231-5100

Plan Your Travel

 
 
 
 

Please Rate this Conference

 0.0
 0.0
 0.0
 0.0
 0.0

Reviews Given by People

No Reviews available. Be the first to write a review.

Hotels Near Venue

Hilton Cincinnati Airport
60.86 miles from venue
Price : USD 114.24 Per Night
Louisville Marriott East
59.29 miles from venue
Price : USD 194.00 Per Night
Origin Hotel Lexington
11.46 miles from venue
Price : USD 0.00 Per Night
21c Museum Hotel Lexington
6.43 miles from venue
Price : USD 219.00 Per Night
Close

Session Details

Session Topic Start Time End Time Location Speakers
Close

Workshop Details

Title Start Time End Time Workshop Fee

Subscribe to our Newsletter

x

Subscribe to our newsletter and receive updates on medical conferences, board review courses and news